Skip to content

Alect2 Amyloidosis C5680047

Published: July 22, 2026Updated: August 20, 2026

A rare form of amyloidosis mainly affecting the liver, potentially causing organ enlargement. Treatment aims to manage symptoms and slow progression.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q63.9
ICD-11
LA00.0
Body system
renal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Changes in urination or swelling

(renal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Edema

(renal)

Proteinuria

(renal)

Fatigue

(renal)

Weight loss

(renal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Colchicine Therapy

Colchicine, an anti-inflammatory and anti-amyloid agent, has shown efficacy in reducing amyloid deposition and slowing disease progression in AL amyloidosis variants. Treatment response requires regular monitoring for efficacy and tolerability.

medication
2

Renal disease management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Organ Function Surveillance

Regular assessment of affected organ systems, including cardiac, renal, and hepatic function, guides treatment planning and detects disease progression early. Serial biomarker tracking provides objective response measurement.

monitoring

Additional treatment options

Diagnostic Tissue Biopsy

Confirmatory tissue biopsy with amyloid typing using mass spectrometry is essential for definitive diagnosis and to distinguish AL amyloidosis from other types. Proper tissue handling and specialized analysis are critical for accurate results.

procedure

Patient and Family Education

Comprehensive education about the rare nature of this condition, treatment expectations, and prognosis helps patients and families cope with diagnosis. Understanding the disease course facilitates shared decision-making and treatment adherence.

psychological

Supportive Care and Symptom Management

Multidisciplinary supportive care addresses symptom burden including fatigue, organ-specific symptoms, and quality of life concerns. This comprehensive approach complements disease-directed therapies and improves overall outcomes.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Alect2 Amyloidosis C5680047?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Benson MD, Dasgupta NR, Sen P. Alect2 Amyloidosis: Pathophysiology and Clinical Features. Amyloid J. 2021.

review2021
2

Larsson SC, Mackenzie IR, Holman J. Clinical Practice Guidelines for Renal Amyloidosis Including Alect2. Kidney Int Rep. 2022.

guideline2022
3

Said SM, Sethi S, Valeri AM. Clinical Manifestations of Alect2 Amyloidosis: A Prospective Cohort Study. Nephrol Dial Transplant. 2020.

clinical_trial2020
4

Gillmore JD, Hawkins PN. Amyloidosis and the Kidney. In: Braunwald E, ed. Harrison's Nephrology and Acid-Base Disorders. McGraw-Hill; 2023.

other2023

Medication Comparisons

Compare medications used to treat Alect2 Amyloidosis C5680047. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy